Ironwood Pharmaceuticals | IRWD - 税前利润



金融业
股票价格
USD
资产
USD 434.57M
现金及等价物
USD 220.47M
销售成本
USD 29.83M
流动资产
USD 332.29M
流动负债
USD 236.31M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.31
股本和储备
USD -217.14M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 666.8M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 113.04M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.24M
应收帐款人
USD 81.89M


税前利润 更改 日
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Almirall EUR 30.32M 22M 2025-12
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
Amarin USD -852K 7.26M 2025-12
Ardelyx USD -37.6M 37.2M 2026-03
Astellas Pharma JPY 186.51B 138.49B 2026-06
AstraZeneca USD 4.81B 894M 2026-06
Charles River Laboratories USD -29.94M 264.16M 2026-03
Coherus Biosciences USD -46.35M 90.86M 2025-12
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Incyte USD 751.51M 407.91M 2026-06
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
MacroGenics USD -36.77M 21.84M 2026-03
Moderna USD -1.33B 535M 2026-03
Myriad Genetics USD 4.6M 3.4M 2025-12
Pacira USD 5M 4.43M 2026-03
PTC Therapeutics USD -2.46M 136.62M 2026-03
Puma Biotechnology USD 20.61M 24.76M 2024-09
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Takeda JPY 162.72B 215.2B 2026-06
Ultragenyx Pharmaceutical USD -91M 93M 2026-06
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12